vs

Side-by-side financial comparison of AerSale Corp (ASLE) and NovoCure Ltd (NVCR). Click either name above to swap in a different company.

NovoCure Ltd is the larger business by last-quarter revenue ($174.1M vs $90.9M, roughly 1.9× AerSale Corp). AerSale Corp runs the higher net margin — 5.9% vs -40.9%, a 46.8% gap on every dollar of revenue. On growth, NovoCure Ltd posted the faster year-over-year revenue change (12.3% vs -4.0%). Over the past eight quarters, NovoCure Ltd's revenue compounded faster (7.6% CAGR vs 0.2%).

AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.

NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.

ASLE vs NVCR — Head-to-Head

Bigger by revenue
NVCR
NVCR
1.9× larger
NVCR
$174.1M
$90.9M
ASLE
Growing faster (revenue YoY)
NVCR
NVCR
+16.3% gap
NVCR
12.3%
-4.0%
ASLE
Higher net margin
ASLE
ASLE
46.8% more per $
ASLE
5.9%
-40.9%
NVCR
Faster 2-yr revenue CAGR
NVCR
NVCR
Annualised
NVCR
7.6%
0.2%
ASLE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASLE
ASLE
NVCR
NVCR
Revenue
$90.9M
$174.1M
Net Profit
$5.4M
$-71.1M
Gross Margin
34.1%
77.6%
Operating Margin
7.8%
Net Margin
5.9%
-40.9%
Revenue YoY
-4.0%
12.3%
Net Profit YoY
99.7%
-107.3%
EPS (diluted)
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASLE
ASLE
NVCR
NVCR
Q1 26
$174.1M
Q4 25
$90.9M
$174.3M
Q3 25
$71.2M
$167.2M
Q2 25
$107.4M
$158.8M
Q1 25
$65.8M
$155.0M
Q4 24
$94.7M
$161.3M
Q3 24
$82.7M
$155.1M
Q2 24
$77.1M
$150.4M
Net Profit
ASLE
ASLE
NVCR
NVCR
Q1 26
$-71.1M
Q4 25
$5.4M
$-24.5M
Q3 25
$-120.0K
$-37.3M
Q2 25
$8.6M
$-40.1M
Q1 25
$-5.3M
$-34.3M
Q4 24
$2.7M
$-65.9M
Q3 24
$509.0K
$-30.6M
Q2 24
$-3.6M
$-33.4M
Gross Margin
ASLE
ASLE
NVCR
NVCR
Q1 26
77.6%
Q4 25
34.1%
75.8%
Q3 25
30.2%
73.2%
Q2 25
32.9%
73.9%
Q1 25
27.3%
75.1%
Q4 24
31.4%
79.2%
Q3 24
28.6%
77.2%
Q2 24
28.2%
77.0%
Operating Margin
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
7.8%
-23.2%
Q3 25
4.0%
-21.5%
Q2 25
11.7%
-24.9%
Q1 25
-10.1%
-24.4%
Q4 24
5.2%
-39.3%
Q3 24
2.4%
-20.7%
Q2 24
-2.4%
-22.3%
Net Margin
ASLE
ASLE
NVCR
NVCR
Q1 26
-40.9%
Q4 25
5.9%
-14.1%
Q3 25
-0.2%
-22.3%
Q2 25
8.0%
-25.3%
Q1 25
-8.0%
-22.1%
Q4 24
2.9%
-40.9%
Q3 24
0.6%
-19.7%
Q2 24
-4.7%
-22.2%
EPS (diluted)
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
$0.10
$-0.22
Q3 25
$0.00
$-0.33
Q2 25
$0.18
$-0.36
Q1 25
$-0.10
$-0.31
Q4 24
$0.05
$-0.61
Q3 24
$0.01
$-0.28
Q2 24
$-0.07
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASLE
ASLE
NVCR
NVCR
Cash + ST InvestmentsLiquidity on hand
$4.4M
$432.0M
Total DebtLower is stronger
$1.3M
Stockholders' EquityBook value
$424.4M
$330.7M
Total Assets
$640.5M
$787.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASLE
ASLE
NVCR
NVCR
Q1 26
$432.0M
Q4 25
$4.4M
$93.5M
Q3 25
$5.3M
$342.1M
Q2 25
$5.7M
$149.6M
Q1 25
$4.7M
$127.3M
Q4 24
$4.7M
$163.8M
Q3 24
$9.8M
$185.4M
Q2 24
$4.3M
$164.8M
Total Debt
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
$1.3M
Q3 25
$1.5M
Q2 25
$907.0K
Q1 25
$1.1M
Q4 24
$1.2M
Q3 24
$376.0K
Q2 24
$522.0K
Stockholders' Equity
ASLE
ASLE
NVCR
NVCR
Q1 26
$330.7M
Q4 25
$424.4M
$340.5M
Q3 25
$417.1M
$341.3M
Q2 25
$415.9M
$349.4M
Q1 25
$406.5M
$362.0M
Q4 24
$455.6M
$360.2M
Q3 24
$451.5M
$360.8M
Q2 24
$449.8M
$361.8M
Total Assets
ASLE
ASLE
NVCR
NVCR
Q1 26
$787.9M
Q4 25
$640.5M
$804.3M
Q3 25
$646.3M
$1.4B
Q2 25
$646.7M
$1.2B
Q1 25
$646.1M
$1.2B
Q4 24
$604.7M
$1.2B
Q3 24
$601.5M
$1.2B
Q2 24
$598.7M
$1.2B
Debt / Equity
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASLE
ASLE
NVCR
NVCR
Operating Cash FlowLast quarter
$11.4M
Free Cash FlowOCF − Capex
$9.8M
FCF MarginFCF / Revenue
10.8%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
2.11×
TTM Free Cash FlowTrailing 4 quarters
$-29.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
$11.4M
$-18.0M
Q3 25
$-8.9M
$20.6M
Q2 25
$19.8M
$-15.9M
Q1 25
$-45.2M
$-35.7M
Q4 24
$37.5M
$-3.5M
Q3 24
$10.4M
$10.4M
Q2 24
$-15.3M
$-1.7M
Free Cash Flow
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
$9.8M
$-22.9M
Q3 25
$-9.8M
$14.9M
Q2 25
$18.6M
$-21.4M
Q1 25
$-47.6M
$-46.3M
Q4 24
$32.3M
$-12.4M
Q3 24
$8.9M
$-307.0K
Q2 24
$-18.9M
$-13.2M
FCF Margin
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
10.8%
-13.1%
Q3 25
-13.8%
8.9%
Q2 25
17.3%
-13.5%
Q1 25
-72.4%
-29.9%
Q4 24
34.0%
-7.7%
Q3 24
10.7%
-0.2%
Q2 24
-24.6%
-8.8%
Capex Intensity
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
1.7%
2.8%
Q3 25
1.3%
3.4%
Q2 25
1.1%
3.5%
Q1 25
3.7%
6.8%
Q4 24
5.6%
5.5%
Q3 24
1.9%
6.9%
Q2 24
4.7%
7.6%
Cash Conversion
ASLE
ASLE
NVCR
NVCR
Q1 26
Q4 25
2.11×
Q3 25
Q2 25
2.31×
Q1 25
Q4 24
13.89×
Q3 24
20.52×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASLE
ASLE

Products$57.8M64%
Maintenance$23.2M26%
Leasing Arrangements$9.9M11%

NVCR
NVCR

Segment breakdown not available.

Related Comparisons